Hrstic Irena, Kalauz Mirjana, Cukovic-Cavka Silvija, Ostojic Rajko, Banfic Ljiljana, Vucelic Boris
Division of Gastroenterology, University Hospital Zagreb - Rebro, Zagreb, Croatia.
Blood Coagul Fibrinolysis. 2007 Sep;18(6):581-3. doi: 10.1097/MBC.0b013e328285d822.
Portal or/and mesenteric vein thrombosis is a rare condition with high mortality in an acute form. Therapy of thrombosis is not well defined, although there are some general guidelines that differ according to disease onset and clinical presentation. In acute thrombosis with bowel infarction, surgical resection with possible thrombolysis is advised. The best therapy for the subacute form is not known and the approach differs between centers. For chronic disease, prolonged anticoagulant therapy is recommended. Thrombolysis is well recognized in the treatment of acute ischemic coronary or cerebral diseases. Success of treatment is better if therapy is introduced within a few hours after symptoms have begun. We describe a 25-year-old patient with the subacute form of extensive portal, mesenteric and ileocolic vein thrombosis in the setting of underlying liver cirrhosis due to autoimmune disease. An aggressive therapeutic approach is advised, especially in patients who will eventually undergo liver transplantation, since portal and/or mesenteric vein thrombosis is relative contraindication for liver transplantation in the majority of transplant centers.
门静脉或/和肠系膜静脉血栓形成是一种罕见疾病,急性形式的死亡率很高。血栓形成的治疗方法尚无明确界定,尽管有一些根据疾病发作和临床表现而有所不同的一般指导原则。对于伴有肠梗死的急性血栓形成,建议进行可能的溶栓手术切除。亚急性形式的最佳治疗方法尚不清楚,各中心的治疗方法也有所不同。对于慢性疾病,建议进行长期抗凝治疗。溶栓在急性缺血性冠状动脉或脑部疾病的治疗中已得到广泛认可。如果在症状开始后的几小时内开始治疗,治疗成功率会更高。我们描述了一名25岁的患者,患有亚急性广泛门静脉、肠系膜和回结肠静脉血栓形成,其基础疾病为自身免疫性疾病导致的肝硬化。建议采取积极的治疗方法,特别是对于最终将接受肝移植的患者,因为在大多数移植中心,门静脉和/或肠系膜静脉血栓形成是肝移植的相对禁忌证。